NDC 13107-032-30 - Mirtazapine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 13107-032
- Requested NDC
- 13107-032-30
- Package NDCs from labels
- 13107-032-34, 13107-032-60, 13107-032-90, 13107-032-01, 13107-032-05, 13107-032-32, 13107-032-30
- Manufacturer
- American Health Packaging
- Effective date
- 2026-07-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Mirtazapine - American Health Packaging | American Health Packaging | 2026-07-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Mirtazapine - Bryant Ranch Prepack | Bryant Ranch Prepack | 2025-11-10 | HUMAN PRESCRIPTION DRUG LABEL |
| Mirtazapine - Aurolife Pharma LLC | Aurobindo Pharma Limited | APL HEALTHCARE LIMITED | Aurolife Pharma LLC | Aurobindo Pharma Limited | APL HEALTHCARE LIMITED | 2025-09-10 | Human Prescription Drug Label |
| Mirtazapine - Preferred Pharmaceuticals, Inc. | Preferred Pharmaceuticals, Inc. | 2024-07-18 | HUMAN PRESCRIPTION DRUG LABEL |
| Mirtazapine - REMEDYREPACK INC. | REMEDYREPACK INC. | 2024-02-15 | HUMAN PRESCRIPTION DRUG LABEL |
| Mirtazapine - Aphena Pharma Solutions - Tennessee, LLC | Aphena Pharma Solutions - Tennessee, LLC | 2019-12-18 | Human Prescription Drug Label |
| Mirtazapine Tablets, USP 7.5 mg, 15 mg, 30 mg, and 45 mg Rx Only | REMEDYREPACK INC. | 2019-04-15 | HUMAN PRESCRIPTION DRUG LABEL |
| Mirtazapine - Contract Pharmacy Services-PA | Coupler Enterprises Inc. | Contract Pharmacy Services-PA | Coupler Enterprises Inc. | 2017-10-03 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-11 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 13107-032-01 | Mirtazapine | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 14 | |
| 13107-032-05 | Mirtazapine | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 14 | |
| 13107-032-32 | Mirtazapine | 30 in 1 BLISTER PACK | TABLET, FILM COATED | 30 | 14 | |
| 13107-032-34 | Mirtazapine | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 14 | |
| 13107-032-60 | Mirtazapine | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | 14 | |
| 13107-032-90 | Mirtazapine | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 14 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 13107-032-05 | EA - Each | 13107-032 | 5d8e602a-b341-47dd-9d95-b9c997a28c25 | 1 | 2012-07-24 |
| 13107-032-30 | EA - Each | 13107-032 | 23fa2f4e-4e88-4db5-b7ee-df88b0fbf47f | 1 | 2013-02-11 |
| 13107-032-34 | EA - Each | 13107-032 | 2eb46fcb-660d-4237-83df-82759e5d0a5b | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.